Thyrotropin

Thyrotropin, in the context of research peptides, refers to the synthetic analogue of endogenous Thyrotropin-Releasing Hormone (TRH), also known by the pharmaceutical name Protirelin. TRH is a tripeptide (pyroglutamyl-histidyl-proline amide) produced by the hypothalamus that travels via the hypothalamic-pituitary portal system to stimulate the anterior pituitary to release Thyroid-Stimulating Hormone (TSH), which in turn drives thyroid hormone production.

TRH/Thyrotropin has a well-established role in neuroendocrine research and clinical endocrinology. The TRH stimulation test - administering a bolus of TRH and measuring the TSH response over 60 minutes - was historically the primary diagnostic tool for distinguishing hypothalamic from pituitary causes of hypothyroidism, and for evaluating the hypothalamic-pituitary-thyroid (HPT) axis reserve. While highly sensitive TSH assays have reduced its routine diagnostic use in primary hypothyroidism assessment, the TRH stimulation test remains valuable in research settings and specialised clinical scenarios.

The mechanism of Thyrotropin involves binding to TRH receptors (TRHR1 and TRHR2) on pituitary thyrotroph cells. These G-protein coupled receptors activate phospholipase C, generating inositol trisphosphate and diacylglycerol, which mobilise intracellular calcium and activate protein kinase C. This signalling cascade drives TSH synthesis and secretion. The resulting TSH elevation stimulates thyroid follicular cells to synthesise and release T4 and T3.

Beyond the classic thyroid axis, TRH has significant CNS activity independent of its pituitary effects. TRH receptors are widely expressed throughout the brain, and TRH functions as a neurotransmitter and neuromodulator in multiple CNS circuits. Research has demonstrated antidepressant-like effects of TRH in animal models, effects on arousal and attention, and neuroprotective properties. These central effects have generated interest in TRH analogues as potential treatments for depression, epilepsy, ALS, and other neurological conditions.

The simultaneous stimulation of prolactin release by Thyrotropin adds a dimension relevant to reproductive and lactation research. TSH and prolactin share regulatory mechanisms at the pituitary level, and TRH's ability to stimulate both provides a tool for studying the intersection of thyroid and reproductive endocrine function.